Marshall Wace, LLP Johnson & Johnson Call Options Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $334,880 - $365,424	2,300 Added 2.71%	87,200 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $2.45 Million - $2.74 Million	15,700 Added 22.69%	84,900 $13.2 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $1.02 Million - $1.1 Million	-6,600 Reduced 8.71%	69,200 $11.5 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $25.5 Million - $30.4 Million	-168,600 Reduced 68.99%	75,800 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $2.53 Million - $2.84 Million	15,800 Added 6.91%	244,400 $43.2 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $34.9 Million - $38.8 Million	216,100 Added 1728.8%	228,600 $37.3 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $1.36 Million - $1.51 Million	8,100 Added 184.09%	12,500 $2.22 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $467,790 - $519,030	3,000 Added 214.29%	4,400 $752,000
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $214,298 - $238,672	1,400 New	1,400 $230,000

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.